DIA Global Chief Executive talks big data, patient engagement and precision medicine
At the DIA 2017 annual meeting, Global Chief Executive Barbara Lopez Kunz shared her passion for DIA and her thoughts on what the future of healthcare holds.
Patient engagement was a highlight of #DIA2017
Patient engagement was a popular topic at this year's Drug Information Association annual meeting in Chicago. During one panel, four experts weighed in on how medicine development should be patient-focused.
presented by
Why Your Patients Are Leaving and How to Stop It
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
PatientsLikeMe-FDA research collaboration seeks to increase patient experience of drugs in post market reviews
PatientsLikeMe and the FDA will explore the potential of patient-generated data to inform regulatory review activities related to risk assessment and risk management.